Cancer
Showing of 88 results
Scientists Turn COVID-19 Immune Memory into a Powerful New Ally Against Cancer
Celloram, Inc., University Hospitals and Case Western Reserve University unveil PROTEXI, a novel cancer vaccine platform advancing toward first-in-human clinical trials in sarcoma patients.
Insurance-Supported Integrative Oncology Program Improves Patients’ Symptoms
New Study Published in JCO Oncology Practice.
Harrington Discovery Institute Researchers Identify New Drug Targets for Hard-to-Treat Cancers
New study of human cancers published in Science Signaling.
Dee and Jimmy Haslam Make $12.5 Million Transformational Investment in Blood Cancer Research and Treatments at University Hospitals
Benefiting patients worldwide, funding accelerates chronic lymphocytic leukemia research and rare cancer drug development through the Oxford-Harrington Rare Disease Centre and UH Seidman Cancer Center.
UH Seidman Cancer Center researchers to test a gut microbiome intervention as part of a cancer therapy regimen
The S2419 BioFront study is chaired by medical oncologist and Miggo Family Chair in Cancer Research, Pedro Barata, MD, M.Sc.
International Harrington Prize Jointly Awarded to Drs. Arul Chinnaiyan and Charles Sawyers
2026 Harrington Prize for Innovation in Medicine recognizes pioneering work in prostate cancer diagnosis and treatment.
Researchers Develop Promising New Therapy for Most Common Form of Bone Cancer in Children and Young Adults
Study published in BMC Medicine.
Landmark Study Finds Limited Survival Benefit from Routine Hormone Therapy with Postoperative Radiation for Prostate Cancer
Research team led by UH Seidman Cancer Center and UCLA published results in The Lancet; Presented at the American Society of Clinical Oncology Genitourinary Symposium.